HCPLive

Rheumatoid Arthritis 
The MD Magazine Rheumatoid Arthritis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Cryptochromes at the Root of Arthritic Morning Stiffness
Atop a growing body of research that examines how rheumatoid arthritis (RA) symptoms are dictated by the body’s circadian rhythms, a recent study seems to explain why so many people-RA sufferers included-wake up each day with stiff joints.
Interleukin-1β (IL-1beta), a cytokine that plays in important role in the body’s immune response, turns out to be part of the body’s early defense system for bacterial infections. Anti-inflammation treatments for autoimmune conditions like rheumatoid arthritis (RA) often times inhibit IL-1beta to mitigate the inflammation that it initiates when infection is detected.
The blistering pace of mobile innovation has opened countless doors for clinical application. Built on Apple's ResearchKit platform, GSK's PARADE app seeks to study rheumatoid arthritis patients in their daily lives.
Patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis still face challenges research has yet to meet, according to the authors: “Given the commonality of comorbidities across all three diseases, there is a degree of overlap in their management.”
A review of well over 100,000 patients in Texas found that breast and prostate cancer patients with rheumatoid arthritis lived roughly two years less than those without.
John D. Reveille, MD, and Philip J. Mease, MD, provide insight on the guidelines for IL-17 inhibition in ankylosing spondylitis, as well as emerging agents and ongoing studies in spondyloarthritis.
A pair of recent studies look in an interesting place to find commonality among rheumatoid arthritis sufferers: their guts.
Professor Aida Babaeva compared cardiovascular effects of immunotherapy plus standard treatments to those evident with the standard treatment alone, claiming the anticytokines doubled chances of reaching target blood pressure and more than halved risk of cardiovascular events.
A new study finds electronic stimulation from implantable bioelectronic devices capable of reducing production of inflammatory agents in rheumatoid arthritis sufferers, a finding its authors consider groundbreaking.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$